A Randomized, Single Blind, Controlled, Longitudinal Study of the Effects of Venlafaxine Hydrochloride Capsules on the Language Function of Stroke ... View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2018-2019

ABSTRACT

Previous studies have demonstrated that venlafaxine significantly improves the language function of healthy subjects and increase of fMRI activation in cortical language area. This study was designed to investigate the relationship between venlafaxine on the cortical language functional reorganization and clinical language improvements in the stroke patients with subcortical aphasia. It is a randomized, controlled, single-blind, longitudinal trial which has approved by the ethics committee of Guangzhou General Hospital of Guangzhou Military Command, and all patients and their guardian should sign an informed consent. The patients will divide into the venlafaxine group and the control group according to the principle of randomization (random number table). The patients in the venlafaxine group begin to take a venlafaxine hydrochloride capsule after enrollment ( each containing venlafaxine 75mg), qd, until 4 weeks after randomization, and the control group do not. Assessments of language functional behavior and examines of functional magnetic resonance imaging (fMRI) should be performed on the first days (V1), 28±3 days (V2) and 90±3 days (V3) after randomization. Through all this procession, we expect improve the language function of participants in experiment and clarify its mechanism,the research may help develop a new treatment for other patients with similar conditions. Detailed Description The cases will recruit from inpatients with acute ischemic stroke in Department of Cerebrovascular disease, The Guangzhou General Hospital of Guangzhou Military Command from June 2018 to June 2019. The diagnose of ischemic stroke is made using the diagnostic criteria of the International Association of Neurological Diseases and Stroke Association in 1982. The classification criteria for subcortical ischemic stroke are based on the current international TOAST etiological classification method. It is a randomized, controlled, single-blind, longitudinal trial which has approved by the ethics committee of Guangzhou General Hospital of Guangzhou Military Command, and all patients and their guardian should sign an informed consent. The patients will divide into the venlafaxine group and the control group according to the principle of randomization (random number table). The patients in the venlafaxine group begin to take a venlafaxine hydrochloride capsule after enrollment ( each containing venlafaxine 75mg), qd, until 4 weeks after randomization, and the control group do not. Assessments of language functional behavior and examines of functional magnetic resonance imaging (fMRI) should be performed on the first days (Visit1,V1), 28±3 days (Visit2, V2) and 90±3 days (Visit3, V3) after randomization. Language functional behavioral assessments included the Chinese version of Western Aphasia Battery(WAB), spontaneous language frequency test(SLFT) and picture naming test(PNT). Examines of fMRI included task-state fMRI and resting-state fMRI. All patients received language rehabilitation training (twice a week, one hour each) which will be conducted by a professional rehabilitation physiotherapist from the Visitation1 until the end of Visitation3. The blood pressure and heart rate of each patient will be monitored and recorded on each visit, and two routine blood tests are performed at V0 and V3, including the blood routine and the liver and kidney function. The test sample quantity is estimated using the sample size estimated by the professional software nQuery Advisor7.0. According to the main evaluation index of the effect of the previous literature on the efficacy of venlafaxine, the experimental group and the control group are 7.5±3.8 and 4.3±2.6,The standard deviation will be 3.26, and 0.05 will be the statistical meaning level (double tail). The test efficiency will be set to 0.83. The balance design will be used to estimate the sample size of the experimental group and the control group in 16 cases. In addition, considering the 20% missing rate, a total of 45 samples will be included in the study. Task-state fMRI: an fMRI block design will be adopted, and DMDX software will be used to present each picture in series alternated between baseline (B) and activation (A) [B-A-B-A-B…]. Thirty-six animal pictures and 36 tool pictures accurately recognized by all subjects will be selected from the Snodgrass picture database. Six blocks of animal naming and six blocks of tool naming will be repeated, and each block continued for 18s with six pictures.the block-design diagram of picture naming task. The abstract figure of an American skunk which is unrecognized by all the subjects will be selected for baseline of animal naming. A schematic drawn arrow will be chosen for baseline picture of tool naming.Patients will be required to silently name the object in each picture without moving their lips. To avoid practice effects, the pictures used for activation will be different from those used in the behavioral evaluation. In the baseline phase, the participants will be asked to identify the orientation of the pictures by silently saying "upright" or "inverted." The subjects will receive task familiarization training prior to the test to ensure that there will be no substantive picture naming but only positional judgment in the baseline task. Rest-state fMRI: During the rest-state fMRI scan, no task instruction will be given to the patient, and the patient will be completely relaxing, closing his eyes, breathing calmly, keeping his head still, but can not fall asleep, try to avoid any systematic thinking activities, scanning 8min. Functional magnetic resonance data acquisition The cranial brain scan will be performed using the US GE HDX3.0 Tesla superconducting magnetic resonance imaging system. The scanning sequence and parameters are as follows: 1. T1 structure imaging using FSPGR BRAVO sequence. The parameters included: time of repetition, 8.86 ms; time of echo, 3.52 ms; field of view, 24×24 cm2; in-plane resolution,256×256; slice thickness, 1 mm;interslice gap, 1 mm; and number of slices, 176. 2. Echo-Planar Imaging (EPI) is used to acquire task-state fMRI data.The parameters included: time of repetition, 3000ms; time of echo, 40 ms; field of view, 24×24 cm2; in-plane resolution,64×64; slice thickness, 4 mm; interslice gap, 1 mm; and number of slices, 34. Scan a sequence of 240s, a total of 12 min. 3. Echo-Planar Imaging (EPI) is used to acquire rest-state fMRI data.The parameters included: time of repetition, 3000ms; time of echo, 40 ms; field of view, 24×24 cm2; in-plane resolution,64×64; slice thickness, 4 mm; interslice gap, 1 mm; and number of slices, 34. A total of 8 min. More... »

URL

https://clinicaltrials.gov/show/NCT03588572

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "Previous studies have demonstrated that venlafaxine significantly improves the language function of healthy subjects and increase of fMRI activation in cortical language area. This study was designed to investigate the relationship between venlafaxine on the cortical language functional reorganization and clinical language improvements in the stroke patients with subcortical aphasia. It is a randomized, controlled, single-blind, longitudinal trial which has approved by the ethics committee of Guangzhou General Hospital of Guangzhou Military Command, and all patients and their guardian should sign an informed consent. The patients will divide into the venlafaxine group and the control group according to the principle of randomization (random number table). The patients in the venlafaxine group begin to take a venlafaxine hydrochloride capsule after enrollment ( each containing venlafaxine 75mg), qd, until 4 weeks after randomization, and the control group do not. Assessments of language functional behavior and examines of functional magnetic resonance imaging (fMRI) should be performed on the first days (V1), 28\u00b13 days (V2) and 90\u00b13 days (V3) after randomization. Through all this procession, we expect improve the language function of participants in experiment and clarify its mechanism,the research may help develop a new treatment for other patients with similar conditions.\n\nDetailed Description\nThe cases will recruit from inpatients with acute ischemic stroke in Department of Cerebrovascular disease, The Guangzhou General Hospital of Guangzhou Military Command from June 2018 to June 2019. The diagnose of ischemic stroke is made using the diagnostic criteria of the International Association of Neurological Diseases and Stroke Association in 1982. The classification criteria for subcortical ischemic stroke are based on the current international TOAST etiological classification method. It is a randomized, controlled, single-blind, longitudinal trial which has approved by the ethics committee of Guangzhou General Hospital of Guangzhou Military Command, and all patients and their guardian should sign an informed consent. The patients will divide into the venlafaxine group and the control group according to the principle of randomization (random number table). The patients in the venlafaxine group begin to take a venlafaxine hydrochloride capsule after enrollment ( each containing venlafaxine 75mg), qd, until 4 weeks after randomization, and the control group do not. Assessments of language functional behavior and examines of functional magnetic resonance imaging (fMRI) should be performed on the first days (Visit1,V1), 28\u00b13 days (Visit2, V2) and 90\u00b13 days (Visit3, V3) after randomization. Language functional behavioral assessments included the Chinese version of Western Aphasia Battery(WAB), spontaneous language frequency test(SLFT) and picture naming test(PNT). Examines of fMRI included task-state fMRI and resting-state fMRI. All patients received language rehabilitation training (twice a week, one hour each) which will be conducted by a professional rehabilitation physiotherapist from the Visitation1 until the end of Visitation3. The blood pressure and heart rate of each patient will be monitored and recorded on each visit, and two routine blood tests are performed at V0 and V3, including the blood routine and the liver and kidney function. The test sample quantity is estimated using the sample size estimated by the professional software nQuery Advisor7.0. According to the main evaluation index of the effect of the previous literature on the efficacy of venlafaxine, the experimental group and the control group are 7.5\u00b13.8 and 4.3\u00b12.6\uff0cThe standard deviation will be 3.26, and 0.05 will be the statistical meaning level (double tail). The test efficiency will be set to 0.83. The balance design will be used to estimate the sample size of the experimental group and the control group in 16 cases. In addition, considering the 20% missing rate, a total of 45 samples will be included in the study. Task-state fMRI: an fMRI block design will be adopted, and DMDX software will be used to present each picture in series alternated between baseline (B) and activation (A) [B-A-B-A-B\u2026]. Thirty-six animal pictures and 36 tool pictures accurately recognized by all subjects will be selected from the Snodgrass picture database. Six blocks of animal naming and six blocks of tool naming will be repeated, and each block continued for 18s with six pictures.the block-design diagram of picture naming task. The abstract figure of an American skunk which is unrecognized by all the subjects will be selected for baseline of animal naming. A schematic drawn arrow will be chosen for baseline picture of tool naming.Patients will be required to silently name the object in each picture without moving their lips. To avoid practice effects, the pictures used for activation will be different from those used in the behavioral evaluation. In the baseline phase, the participants will be asked to identify the orientation of the pictures by silently saying \"upright\" or \"inverted.\" The subjects will receive task familiarization training prior to the test to ensure that there will be no substantive picture naming but only positional judgment in the baseline task. Rest-state fMRI: During the rest-state fMRI scan, no task instruction will be given to the patient, and the patient will be completely relaxing, closing his eyes, breathing calmly, keeping his head still, but can not fall asleep, try to avoid any systematic thinking activities, scanning 8min. Functional magnetic resonance data acquisition The cranial brain scan will be performed using the US GE HDX3.0 Tesla superconducting magnetic resonance imaging system. The scanning sequence and parameters are as follows: 1. T1 structure imaging using FSPGR BRAVO sequence. The parameters included: time of repetition, 8.86 ms; time of echo, 3.52 ms; field of view, 24\u00d724 cm2; in-plane resolution,256\u00d7256; slice thickness, 1 mm;interslice gap, 1 mm; and number of slices, 176. 2. Echo-Planar Imaging (EPI) is used to acquire task-state fMRI data.The parameters included: time of repetition, 3000ms; time of echo, 40 ms; field of view, 24\u00d724 cm2; in-plane resolution,64\u00d764; slice thickness, 4 mm; interslice gap, 1 mm; and number of slices, 34. Scan a sequence of 240s, a total of 12 min. 3. Echo-Planar Imaging (EPI) is used to acquire rest-state fMRI data.The parameters included: time of repetition, 3000ms; time of echo, 40 ms; field of view, 24\u00d724 cm2; in-plane resolution,64\u00d764; slice thickness, 4 mm; interslice gap, 1 mm; and number of slices, 34. A total of 8 min.", 
    "endDate": "2019-08-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT03588572", 
    "keywords": [
      "single-blind", 
      "Study of the Effect", 
      "language function", 
      "stroke patient", 
      "aphasia", 
      "previous study", 
      "venlafaxine", 
      "healthy subject", 
      "fMRI activation", 
      "language area", 
      "functional reorganization", 
      "improvement", 
      "longitudinal trial", 
      "ethic committee", 
      "Guangzhou", 
      "General Hospital", 
      "command", 
      "patient", 
      "guardian", 
      "informed consent", 
      "control group", 
      "principle", 
      "Random Allocation", 
      "random number", 
      "enrollment", 
      "QDs", 
      "assessment", 
      "functional behavior", 
      "Magnetic Resonance Imaging", 
      "V1", 
      "V2", 
      "V3", 
      "procession", 
      "experiment", 
      "similar condition", 
      "inpatient", 
      "acute ischemic stroke", 
      "cerebrovascular", 
      "disease", 
      "June", 
      "diagnose", 
      "ischemic stroke", 
      "diagnostic criterion", 
      "International Association", 
      "neurological disease", 
      "association", 
      "classification", 
      "classification method", 
      "behavioral assessment", 
      "version", 
      "western", 
      "frequency", 
      "picture naming", 
      "PNT", 
      "Examine", 
      "resting-state functional magnetic resonance imaging", 
      "rehabilitation", 
      "blood pressure", 
      "heart rate", 
      "visit", 
      "routine", 
      "blood", 
      "liver", 
      "kidney function", 
      "quantity", 
      "sample size", 
      "professional", 
      "index", 
      "previous literature", 
      "efficacy", 
      "experimental group", 
      "standard deviation", 
      "meaning", 
      "tail", 
      "efficiency", 
      "balance", 
      "sample", 
      "software", 
      "picture", 
      "baseline", 
      "A-B", 
      "database", 
      "animal", 
      "naming", 
      "diagram", 
      "figure", 
      "american", 
      "arrow", 
      "name", 
      "lip", 
      "practice effect", 
      "behavioral evaluation", 
      "orientation", 
      "upright", 
      "familiarization", 
      "judgment", 
      "task", 
      "relaxing", 
      "eye", 
      "respiration", 
      "head", 
      "thinking", 
      "scanning", 
      "data acquisition", 
      "brain", 
      "Ge", 
      "magnetic resonance imaging system", 
      "parameter", 
      "imaging", 
      "sequence", 
      "repetition", 
      "echo", 
      "cm2", 
      "in-plane", 
      "thickness", 
      "mm", 
      "gap", 
      "slice", 
      "Echo-Planar Imaging", 
      "functional magnetic resonance imaging data", 
      "scan", 
      "min"
    ], 
    "name": "A Randomized, Single Blind, Controlled, Longitudinal Study of the Effects of Venlafaxine Hydrochloride Capsules on the Language Function of Stroke Patients With Subcortical Aphasia Using fMRI", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT03588572"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00027.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.413435.4", 
        "type": "Organization"
      }
    ], 
    "startDate": "2018-08-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "https://doi.org/10.1080/13803390490515397", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000527069"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/13554790701595471", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000682913"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.str.0000221233.55497.51", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001963641"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/380499a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005507851", 
          "https://doi.org/10.1038/380499a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0028-3932(70)90022-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006289935"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002512-200522020-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013306810", 
          "https://doi.org/10.2165/00002512-200522020-00006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11065-011-9177-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015313832", 
          "https://doi.org/10.1007/s11065-011-9177-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.psychres.2010.03.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018668241"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.2044-8341.1959.tb00467.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025431669"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.str.24.1.35", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026601739"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1192/bjp.178.3.234", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027190344"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0022-3956(75)90026-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027523106"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.biopsych.2007.06.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029600130"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00406-008-0849-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031067256", 
          "https://doi.org/10.1007/s00406-008-0849-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/jcp.0000000000000056", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031273512"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0028-3908(00)00018-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036171034"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.str.0000139323.76769.b0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036945537"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/hs0901.095720", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039608970"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.2044-8260.1967.tb00530.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041467340"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.jcp.0000138764.31106.60", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043659242"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.apmr.2009.09.020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046359607"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/13543784.6.1.65", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046818251"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00213-012-2730-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049335338", 
          "https://doi.org/10.1007/s00213-012-2730-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00406-009-0003-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050847827", 
          "https://doi.org/10.1007/s00406-009-0003-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.410380416", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051443574"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.str.0000221815.64093.8c", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053468773"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1017/s1461145705006413", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054933077"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1017/s1461145708008766", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054933261"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/jwh.2005.14.609", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059290412"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00004714-199804000-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060188119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079559036", 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT03588572"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT03588572'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT03588572'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT03588572'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT03588572'


 

This table displays all metadata directly associated to this object as RDF triples.

239 TRIPLES      16 PREDICATES      168 URIs      131 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT03588572 schema:about anzsrc-for:3053
2 schema:description Previous studies have demonstrated that venlafaxine significantly improves the language function of healthy subjects and increase of fMRI activation in cortical language area. This study was designed to investigate the relationship between venlafaxine on the cortical language functional reorganization and clinical language improvements in the stroke patients with subcortical aphasia. It is a randomized, controlled, single-blind, longitudinal trial which has approved by the ethics committee of Guangzhou General Hospital of Guangzhou Military Command, and all patients and their guardian should sign an informed consent. The patients will divide into the venlafaxine group and the control group according to the principle of randomization (random number table). The patients in the venlafaxine group begin to take a venlafaxine hydrochloride capsule after enrollment ( each containing venlafaxine 75mg), qd, until 4 weeks after randomization, and the control group do not. Assessments of language functional behavior and examines of functional magnetic resonance imaging (fMRI) should be performed on the first days (V1), 28±3 days (V2) and 90±3 days (V3) after randomization. Through all this procession, we expect improve the language function of participants in experiment and clarify its mechanism,the research may help develop a new treatment for other patients with similar conditions. Detailed Description The cases will recruit from inpatients with acute ischemic stroke in Department of Cerebrovascular disease, The Guangzhou General Hospital of Guangzhou Military Command from June 2018 to June 2019. The diagnose of ischemic stroke is made using the diagnostic criteria of the International Association of Neurological Diseases and Stroke Association in 1982. The classification criteria for subcortical ischemic stroke are based on the current international TOAST etiological classification method. It is a randomized, controlled, single-blind, longitudinal trial which has approved by the ethics committee of Guangzhou General Hospital of Guangzhou Military Command, and all patients and their guardian should sign an informed consent. The patients will divide into the venlafaxine group and the control group according to the principle of randomization (random number table). The patients in the venlafaxine group begin to take a venlafaxine hydrochloride capsule after enrollment ( each containing venlafaxine 75mg), qd, until 4 weeks after randomization, and the control group do not. Assessments of language functional behavior and examines of functional magnetic resonance imaging (fMRI) should be performed on the first days (Visit1,V1), 28±3 days (Visit2, V2) and 90±3 days (Visit3, V3) after randomization. Language functional behavioral assessments included the Chinese version of Western Aphasia Battery(WAB), spontaneous language frequency test(SLFT) and picture naming test(PNT). Examines of fMRI included task-state fMRI and resting-state fMRI. All patients received language rehabilitation training (twice a week, one hour each) which will be conducted by a professional rehabilitation physiotherapist from the Visitation1 until the end of Visitation3. The blood pressure and heart rate of each patient will be monitored and recorded on each visit, and two routine blood tests are performed at V0 and V3, including the blood routine and the liver and kidney function. The test sample quantity is estimated using the sample size estimated by the professional software nQuery Advisor7.0. According to the main evaluation index of the effect of the previous literature on the efficacy of venlafaxine, the experimental group and the control group are 7.5±3.8 and 4.3±2.6,The standard deviation will be 3.26, and 0.05 will be the statistical meaning level (double tail). The test efficiency will be set to 0.83. The balance design will be used to estimate the sample size of the experimental group and the control group in 16 cases. In addition, considering the 20% missing rate, a total of 45 samples will be included in the study. Task-state fMRI: an fMRI block design will be adopted, and DMDX software will be used to present each picture in series alternated between baseline (B) and activation (A) [B-A-B-A-B…]. Thirty-six animal pictures and 36 tool pictures accurately recognized by all subjects will be selected from the Snodgrass picture database. Six blocks of animal naming and six blocks of tool naming will be repeated, and each block continued for 18s with six pictures.the block-design diagram of picture naming task. The abstract figure of an American skunk which is unrecognized by all the subjects will be selected for baseline of animal naming. A schematic drawn arrow will be chosen for baseline picture of tool naming.Patients will be required to silently name the object in each picture without moving their lips. To avoid practice effects, the pictures used for activation will be different from those used in the behavioral evaluation. In the baseline phase, the participants will be asked to identify the orientation of the pictures by silently saying "upright" or "inverted." The subjects will receive task familiarization training prior to the test to ensure that there will be no substantive picture naming but only positional judgment in the baseline task. Rest-state fMRI: During the rest-state fMRI scan, no task instruction will be given to the patient, and the patient will be completely relaxing, closing his eyes, breathing calmly, keeping his head still, but can not fall asleep, try to avoid any systematic thinking activities, scanning 8min. Functional magnetic resonance data acquisition The cranial brain scan will be performed using the US GE HDX3.0 Tesla superconducting magnetic resonance imaging system. The scanning sequence and parameters are as follows: 1. T1 structure imaging using FSPGR BRAVO sequence. The parameters included: time of repetition, 8.86 ms; time of echo, 3.52 ms; field of view, 24×24 cm2; in-plane resolution,256×256; slice thickness, 1 mm;interslice gap, 1 mm; and number of slices, 176. 2. Echo-Planar Imaging (EPI) is used to acquire task-state fMRI data.The parameters included: time of repetition, 3000ms; time of echo, 40 ms; field of view, 24×24 cm2; in-plane resolution,64×64; slice thickness, 4 mm; interslice gap, 1 mm; and number of slices, 34. Scan a sequence of 240s, a total of 12 min. 3. Echo-Planar Imaging (EPI) is used to acquire rest-state fMRI data.The parameters included: time of repetition, 3000ms; time of echo, 40 ms; field of view, 24×24 cm2; in-plane resolution,64×64; slice thickness, 4 mm; interslice gap, 1 mm; and number of slices, 34. A total of 8 min.
3 schema:endDate 2019-08-01T00:00:00Z
4 schema:keywords A-B
5 Echo-Planar Imaging
6 Examine
7 Ge
8 General Hospital
9 Guangzhou
10 International Association
11 June
12 Magnetic Resonance Imaging
13 PNT
14 QDs
15 Random Allocation
16 Study of the Effect
17 V1
18 V2
19 V3
20 acute ischemic stroke
21 american
22 animal
23 aphasia
24 arrow
25 assessment
26 association
27 balance
28 baseline
29 behavioral assessment
30 behavioral evaluation
31 blood
32 blood pressure
33 brain
34 cerebrovascular
35 classification
36 classification method
37 cm2
38 command
39 control group
40 data acquisition
41 database
42 diagnose
43 diagnostic criterion
44 diagram
45 disease
46 echo
47 efficacy
48 efficiency
49 enrollment
50 ethic committee
51 experiment
52 experimental group
53 eye
54 fMRI activation
55 familiarization
56 figure
57 frequency
58 functional behavior
59 functional magnetic resonance imaging data
60 functional reorganization
61 gap
62 guardian
63 head
64 healthy subject
65 heart rate
66 imaging
67 improvement
68 in-plane
69 index
70 informed consent
71 inpatient
72 ischemic stroke
73 judgment
74 kidney function
75 language area
76 language function
77 lip
78 liver
79 longitudinal trial
80 magnetic resonance imaging system
81 meaning
82 min
83 mm
84 name
85 naming
86 neurological disease
87 orientation
88 parameter
89 patient
90 picture
91 picture naming
92 practice effect
93 previous literature
94 previous study
95 principle
96 procession
97 professional
98 quantity
99 random number
100 rehabilitation
101 relaxing
102 repetition
103 respiration
104 resting-state functional magnetic resonance imaging
105 routine
106 sample
107 sample size
108 scan
109 scanning
110 sequence
111 similar condition
112 single-blind
113 slice
114 software
115 standard deviation
116 stroke patient
117 tail
118 task
119 thickness
120 thinking
121 upright
122 venlafaxine
123 version
124 visit
125 western
126 schema:name A Randomized, Single Blind, Controlled, Longitudinal Study of the Effects of Venlafaxine Hydrochloride Capsules on the Language Function of Stroke Patients With Subcortical Aphasia Using fMRI
127 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT03588572
128 schema:sdDatePublished 2019-03-07T15:27
129 schema:sdLicense https://scigraph.springernature.com/explorer/license/
130 schema:sdPublisher Nd5bc5507ef224dd78249a52cc1053598
131 schema:sponsor https://www.grid.ac/institutes/grid.413435.4
132 schema:startDate 2018-08-01T00:00:00Z
133 schema:subjectOf sg:pub.10.1007/s00213-012-2730-0
134 sg:pub.10.1007/s00406-008-0849-0
135 sg:pub.10.1007/s00406-009-0003-7
136 sg:pub.10.1007/s11065-011-9177-7
137 sg:pub.10.1038/380499a0
138 sg:pub.10.2165/00002512-200522020-00006
139 https://app.dimensions.ai/details/publication/pub.1079559036
140 https://doi.org/10.1002/ana.410380416
141 https://doi.org/10.1016/0022-3956(75)90026-6
142 https://doi.org/10.1016/0028-3932(70)90022-9
143 https://doi.org/10.1016/j.apmr.2009.09.020
144 https://doi.org/10.1016/j.biopsych.2007.06.027
145 https://doi.org/10.1016/j.psychres.2010.03.006
146 https://doi.org/10.1016/s0028-3908(00)00018-6
147 https://doi.org/10.1017/s1461145705006413
148 https://doi.org/10.1017/s1461145708008766
149 https://doi.org/10.1080/13554790701595471
150 https://doi.org/10.1080/13803390490515397
151 https://doi.org/10.1089/jwh.2005.14.609
152 https://doi.org/10.1097/00004714-199804000-00006
153 https://doi.org/10.1097/01.jcp.0000138764.31106.60
154 https://doi.org/10.1097/jcp.0000000000000056
155 https://doi.org/10.1111/j.2044-8260.1967.tb00530.x
156 https://doi.org/10.1111/j.2044-8341.1959.tb00467.x
157 https://doi.org/10.1161/01.str.0000139323.76769.b0
158 https://doi.org/10.1161/01.str.0000221233.55497.51
159 https://doi.org/10.1161/01.str.0000221815.64093.8c
160 https://doi.org/10.1161/01.str.24.1.35
161 https://doi.org/10.1161/hs0901.095720
162 https://doi.org/10.1192/bjp.178.3.234
163 https://doi.org/10.1517/13543784.6.1.65
164 schema:url https://clinicaltrials.gov/show/NCT03588572
165 sgo:license sg:explorer/license/
166 sgo:sdDataset clinical_trials
167 rdf:type schema:MedicalStudy
168 Nd5bc5507ef224dd78249a52cc1053598 schema:name Springer Nature - SN SciGraph project
169 rdf:type schema:Organization
170 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
171 rdf:type schema:DefinedTerm
172 sg:pub.10.1007/s00213-012-2730-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049335338
173 https://doi.org/10.1007/s00213-012-2730-0
174 rdf:type schema:CreativeWork
175 sg:pub.10.1007/s00406-008-0849-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031067256
176 https://doi.org/10.1007/s00406-008-0849-0
177 rdf:type schema:CreativeWork
178 sg:pub.10.1007/s00406-009-0003-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050847827
179 https://doi.org/10.1007/s00406-009-0003-7
180 rdf:type schema:CreativeWork
181 sg:pub.10.1007/s11065-011-9177-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015313832
182 https://doi.org/10.1007/s11065-011-9177-7
183 rdf:type schema:CreativeWork
184 sg:pub.10.1038/380499a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005507851
185 https://doi.org/10.1038/380499a0
186 rdf:type schema:CreativeWork
187 sg:pub.10.2165/00002512-200522020-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013306810
188 https://doi.org/10.2165/00002512-200522020-00006
189 rdf:type schema:CreativeWork
190 https://app.dimensions.ai/details/publication/pub.1079559036 schema:CreativeWork
191 https://doi.org/10.1002/ana.410380416 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051443574
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1016/0022-3956(75)90026-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027523106
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1016/0028-3932(70)90022-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006289935
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1016/j.apmr.2009.09.020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046359607
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1016/j.biopsych.2007.06.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029600130
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1016/j.psychres.2010.03.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018668241
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1016/s0028-3908(00)00018-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036171034
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1017/s1461145705006413 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054933077
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1017/s1461145708008766 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054933261
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1080/13554790701595471 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000682913
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1080/13803390490515397 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000527069
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1089/jwh.2005.14.609 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059290412
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1097/00004714-199804000-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060188119
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1097/01.jcp.0000138764.31106.60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043659242
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1097/jcp.0000000000000056 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031273512
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1111/j.2044-8260.1967.tb00530.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1041467340
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1111/j.2044-8341.1959.tb00467.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1025431669
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1161/01.str.0000139323.76769.b0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036945537
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1161/01.str.0000221233.55497.51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001963641
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1161/01.str.0000221815.64093.8c schema:sameAs https://app.dimensions.ai/details/publication/pub.1053468773
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1161/01.str.24.1.35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026601739
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1161/hs0901.095720 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039608970
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1192/bjp.178.3.234 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027190344
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1517/13543784.6.1.65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046818251
238 rdf:type schema:CreativeWork
239 https://www.grid.ac/institutes/grid.413435.4 schema:Organization
 




Preview window. Press ESC to close (or click here)


...